Clinical Trials Browser

Expanded_access × magrolimab × Other hematologic neoplasm × Clear all

NCT05627466 2024-02-15

US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia

No longer available

Other hematologic neoplasm

Leukemia, Myeloid, Acute